-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. What You Will Achieve As an Associate Scientist, you will be
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. What You Will Achieve The associate scientist is responsible
-
-leading team whose mission is to identify key risks associated with unwanted clinical immunogenicity and influence drug design to mitigate those risks. We are currently seeking an experienced immunogenicity
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. ROLE SUMMARY As a member of our NGS and Data Science team, you will
-
cutting edge design and process development capabilities to accelerate and bring the best-in-class medicines to patients around the world. What You Will Achieve As part of the Comparative Medicine team, you
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. What You Will Achieve As a highly skilled and motivated Principal
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. What You Will Achieve As a Senior Associate Scientist, you will be
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. POSITION SUMMARY Pfizer's Oncology Research Unit (ORU) in La Jolla
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. What You Will Achieve The Senior Associate Scientist is responsible
-
The annual base salary for this position ranges from $64,600.00 to $107,600.00. In addition, this position is eligible for participation in Pfizer's Global Performance Plan with a bonus target of 7.5